Sodium ipodate (oragrafin) in the preoperative preparation of graves hyperthyroidism

Laryngoscope

Volumn 107, Issue 8, 1997, Pages 1066-1070

  Tomaski, Sharon M ^a   Mahoney, Eileen M ^a   Burgess, Lawrence P A ^a   Raines, Kristen B ^a   Bornemann, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IOPODATE SODIUM; LIOTHYRONINE; PROPYLTHIOURACIL; THYROXINE;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIOTHYRONINE BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; PREOPERATIVE CARE; PRIORITY JOURNAL; THYROIDECTOMY; THYROXINE BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTITHYROID AGENTS; BLOOD LOSS, SURGICAL; FEMALE; GRAVES DISEASE; HUMANS; IPODATE; MALE; PREMEDICATION; PREOPERATIVE CARE; PROPYLTHIOURACIL; RETROSPECTIVE STUDIES; THYROID GLAND; THYROIDECTOMY; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0030825482     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199708000-00012     Document Type: Conference Paper

References (32)

1. Cristofori CC, Duncan GG. Effect of a new orally administered cholecystographic compound on the 131 triiodothyronine red-cell uptake test of thyroid function. N Engl J Med 1964; 271:564-5.
2. Wu SY, Chopra IJ, Solomon DH, et al. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin): an agent for oral cholecystography. J Clin Endocrinol Metab 1978;46(4):691-8.
3. DeGroot LJ, Rue PA. Roentgenographic contrast agents inhibit triiodothyronine binding to nuclear receptors in vitro. J Clin Endocrinol Metab 1978;49:538-42.
4. Chopra IJ. Inhibition of outer ring monodeiodination of T4 and reverse T3 (rT3) by some radiocontrast agents. Clin Res 1978;26:303A.
5. Felicetta JV, Green WL, Nelp WB. Inhibition of hepatic binding of thyroxine by cholecystographic agents. J Clin Invest 1980;65:1032-40.
6. Wu SY, Chopra IJ, Solomon DH, et al. The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism. J Clin Endocrinol Metab 1978;47:1358-62.
7. Laurberg P. The effect of some iodine-containing radiocontrast agents on iodothyronine secretion from the perfused canine thyroid. Endocrinology 1982;111:1904-8.
8. Laurberg P. Multisite inhibition by ipodate of iodothyronine secretion from perfused dog thyroid lobes. Endocrinology 1985;117:1639-44.
9. Felicetta JV, Green WL, Huber-Smith MJ. Effects of cholecystographic agents and sulfobromopthalein on binding of thyroid hormones to serum proteins. J Clin Endocrinol Metab 1983;57:207-12.
10. Berghout A, Wiersinga WM, Brummelkamp WH. Sodium ipodate in the preparation of Graves' hyperthyroid patients for thyroidectomy. Horm Res 1989;31:256-60.
11. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994;330:1731-8.
12. Thyroid Guidelines Task Force, M. Garcia (Chairman). AACE Clinical Practice Guidelines for the Evaluation and Treatment of Hyperthyroidism and Hypothyroidism. Jacksonville, FL: American Association of Clinical Endocrinologists and American College of Endocrinology, January 1995.
13. Tallstedt L, Lundell G, Torring O, et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 1992;326:1733-8.
14. Feek CM, Sawers JS, Irvine WJ, et al. Combination of potassium iodine and propranolol in preparation of patients with Graves' disease for thyroid surgery. N Engl J Med 1980; 302:883-5.
15. Falk SA. The management of hyperthyroidism: a surgeon's perspective. Otolaryngol Clin North Am 1990;23:361-79.
16. Cooper DS. Treatment of thyrotoxicosis. In: Braverman LD, Utiger RD, eds. Werner and Ingbar's The Thyroid. 6th ed. Philadelphia: JB Lippincott; 1991.
17. Astwood EB. Chemotherapy of hyperthryoidism. Harvey Lect 1945;40:195-235.
18. Geffner DL, Azukizawa M, Hershman JM. Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. J Clin Invest 1975;55:224-9.
19. Furth ED, Rivers K, Becker DV. Nonthyroidal action of propylthiouracil in euthyroid, hypothyroid and hyperthyroid man. J Clin Endocrinol Metab 1966;26:239-49.
20. Kodding R, Hoffkin B. Thyroxine and its metabolites during treatment with propylthiouracil and mercaptoimidazole. Acta Endocrinol 1978;215(suppl 87):74-8.
21. Zonszein J, Santangelo RP, Mackin JF, et al. Propranolol therapy in thyrotoxicosis: a review of 84 patients undergoing surgery. Am J Med 1979;66:411-6.
22. Lee KS, Kim K, Hur KB, et al. The role of propranolol in the preoperative preparation of patients with Graves' disease. Surg Gynecol Obstet 1986;162:365-9.
23. Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 1948;174: 555-64.
24. Wartofsky L, Ransil BJ, Ingbar SH. Inhibition by iodine of the release of thyroxine form the thyroids glands of patients with thyrotoxicosis. J Clin Invest 1970;49:78-86.
25. Emerson CH, Anderson AJ, Howard WJ, et al. Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J Clin Endocrinol Metab 1975; 40:33-6.
26. LiVolsi VA. Surgical Pathology of the Thyroid. Philadelphia: W.B. Saunders; 1990:178-84.
27. Shen DC, Wu SY, Chopra IJ, et al. Long-term treatment of Graves hyperthyroidism with sodium ipodate. J Clin Endocrinol Metab 1985;61:723-7.
28. Wu SY, Shyh TP, Chopra IJ, et al. Comparison of sodium ipodate (Oragrafin) and propylthiouracil in early treatment of hyperthyroidism. J Clin Endocrinol Metab 1982;54: 630-4.
29. Sharp B, Reed AW, Tamagna EI, Geffner DL, Hershman JM. Treatment of hyperthyroidism with sodium ipodate (Oragrafin) in addition to propylthiouracil and propranolol. J Clin Endocrinol Metabol 1981;53:622-5.
30. Kamel N, Uysal AR, Kologlu S, et al. Sodium ipodate in the treatment of toxic diffuse goiter: short-term and long effects on thyrotoxicosis. Rom J Med 1988;26:99-105.
31. Caldwell G, Errington M, Toft AD. Resistant hyperthyroidism induced by sodium ipodate used as treatment for Graves' disease. Acta Endocrinol (Copenh) 1989;120:215-6.
32. Roti E, Robuschi G, Manfredi A. Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. Clin Endocrinol 1985;22:489-96.